Augusto Hsia, MD

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.